Across TCGA pan-cancer cohorts, KATNBL1P6 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of KATNBL1P6’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where KATNBL1P6 RNA is repressed in tumor relative to normal tissue. In most cancer types KATNBL1P6 is over-expressed in tumor, although a few such as KIRC and KIRP show the opposite, repressed pattern.

KIRC, COAD, and KIRP are the cancer types where KATNBL1P6 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in KATNBL1P6 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Male	III,IV	−0.055	<.001	9	view →
COAD	All	All	+0.085	.017	2	view →
KIRP	Female	II,III,IV	−0.066	.022	2	view →
KICH	Male	All	−0.057	.012	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: KATNBL1P6 RNA expression & survival · all KATNBL1P6 data types